Bristol-Myers, Alder To Pursue Rheumatoid Arthritis Drug Tests - Wall Street Journal

Bristol-Myers, Alder To Pursue Rheumatoid Arthritis Drug Tests Wall Street Journal ACR scores are a standardized measure of percentage improvement in rheumatoid arthritis signs and symptoms. The most commonly reported side effects were ... New Data for Investigational Antibody Blocking IL-6 in Rheumatoid Arthritis ...MarketWatch (press release) Bristol-Myers says arthritis drug trial met goalReuters RA drug safety trial successfulPharmacy Europe all 111 news articles »

Horizon Pharma, Inc. Presents Results of Phase 3 Studies of LODOTRA(R ... - PR Newswire (press release)

Horizon Pharma, Inc. Presents Results of Phase 3 Studies of LODOTRA(R ... PR Newswire (press release) "Conditions like rheumatoid arthritis follow a very distinct circadian rhythm, in which symptoms are more severe at a specific time of day. ... and more »

Long-term Cimzia® (certolizumab pegol) Data Demonstrated Rapid Sustained ... - PR Newswire (press release)

Long-term Cimzia® (certolizumab pegol) Data Demonstrated Rapid Sustained ... PR Newswire (press release) It is also approved for the treatment of adults with moderately to severely active rheumatoid arthritis. Certolizumab pegol was approved in Switzerland for ... Two-year Cimzia® (certolizumab pegol) data from study showed sustained ...PR-inside.com (press release) UCB (BE) - Cimzia (certolizumab pegol) shows sustained clinical improvements ...PharmaLive.com (press release) all 9 news articles »

NATURE Publishes New Dynavax Findings on Novel Role of TLRs in Lupus - MarketWatch (press release)

NATURE Publishes New Dynavax Findings on Novel Role of TLRs in Lupus MarketWatch (press release) ... IFN-alpha and also reduce symptoms in multiple autoimmune disease animal models, such as lupus, inflammatory skin disorders, and rheumatoid arthritis. ... and more »